InvestorsHub Logo
Followers 67
Posts 1297
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Saturday, 02/22/2020 8:40:09 AM

Saturday, February 22, 2020 8:40:09 AM

Post# of 703719
Still remember this slide, slide 28 of Dr.Bosch's presentation given December 2019:

https://nwbio.com/wp-content/uploads/Boston-Presentation-v0.2.pdf

" (Near) Future Plans in Brain Cancer

•Unblinding and analyzing the Phase III data

•Combination trials of DCVax®-L with checkpoint inhibitor molecules

•Intratumoral injection of DCVax®-Direct (a related product) in brain metastases

•Intratumoral injection of DCVax®-Direct in diffuse intrinsic pontine glioma (DIPG)"

And now remember the news of annual shareholder meeting of 18 Feb 2020, to be held on 18 April 2020:

https://finance.yahoo.com/news/nw-bio-announces-annual-shareholders-141500981.html

Then it's pretty much reasonable that we are currently in the process of unblinding and analysis of TLD.

Anytime I hears someone says buying nwbo shares is like buying a lottery ticket, I feel it's an insult to the collective DD of so many true longs who have invested heavily based on own profound knowledge of cancer vaccine immunotherapy applied for GBM, the known blinded data and decades of stagnation deprived of any concrete progress in treating GBM patients; we have a thick and long tail of patients indicative from the blinded data, and a very significant portion of patients who live longer than the known prognostic factors can explain ...

Of course, nobody is certain the DCVax-L P3 trial will be approved successful and the vaccine will be approved by FDA, etc., but the odds of that kind of success is very high based on what we have known.

I hope what is developing in the near future will finalize my decision whether going to washington DC or not, and then see you all in the meeting!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News